Muscle Pharm Corporation (MSLPQ)

[Bulldog2]

Earnings is still the name of the game. When a start-up like Muscle Pharm has good revenue growth, investors try to calculate future earning before taxes and depreciation. In the end MP will be valued at 10X or 12X earnings.

The rapid dilution, high spend, poor communication and lack of trust in ownership will continue to kill this stock.

Management needs to show earnings and a growth plan that minimizes dilution or the stock price will stay in the cellar. Let's face it, most of the dilution is NOT coming from planned expansion. It is just to meet daily expenses. The big dilution is yet to hit!